Cellectis (CLLS) Gross Margin Growth (1y) (2016 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 526.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -5.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -165.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 21,616.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4,072.00 |
| Sep 30, 2023 | -2,706.00 |
| Jun 30, 2023 | -573.00 |
| Mar 31, 2023 | -21,716.00 |
| Dec 31, 2022 | 95.00 |
| Sep 30, 2022 | -9,887.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 869.00 |
| Dec 31, 2021 | 3,592.00 |
| Sep 30, 2021 | 1,572.00 |
| Jun 30, 2021 | 9,576.00 |
| Mar 31, 2021 | -2,264.00 |
| Dec 31, 2020 | -881.00 |
| Sep 30, 2020 | -7,641.00 |
| Jun 30, 2020 | -13,018.00 |
| Mar 31, 2020 | 4,739.00 |
| Dec 31, 2019 | -5,341.00 |
| Sep 30, 2019 | 4,566.00 |
| Jun 30, 2019 | -5,968.00 |
| Mar 31, 2019 | -4,698.00 |
| Dec 31, 2018 | -6,160.00 |
| Sep 30, 2018 | -8,651.00 |
| Jun 30, 2018 | 8,571.00 |
| Mar 31, 2018 | -57.00 |
| Dec 31, 2017 | -527.00 |
| Sep 30, 2017 | -619.00 |
| Jun 30, 2017 | -4,804.00 |
| Mar 31, 2017 | -281.00 |
| Dec 31, 2016 | -351.00 |
| Sep 30, 2016 | 129.00 |
| Jun 30, 2016 | -4,339.00 |
| Mar 31, 2016 | -114.00 |